The association between AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2) and Lipodystrophy, Congenital Generalized, Type 1 is well established and manually curated, with its 5 contributing sources — 4 of them expert-curated — recording a known molecular basis, pathogenic and likely-pathogenic variants, and a causative germline mutation.
Sources5
Clinical variants170
Symptoms55
Compounds0
Trials0
Publications13
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.